Geode Capital Management’s LAVA Therapeutics LVTX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $18.7K | Sell |
14,170
-1,994
| -12% | -$2.63K | ﹤0.01% | 4368 |
|
2025
Q1 | $20.5K | Hold |
16,164
| – | – | ﹤0.01% | 4340 |
|
2024
Q4 | $15.4K | Buy |
16,164
+5,040
| +45% | +$4.79K | ﹤0.01% | 4406 |
|
2024
Q3 | $18.5K | Hold |
11,124
| – | – | ﹤0.01% | 4402 |
|
2024
Q2 | $20K | Hold |
11,124
| – | – | ﹤0.01% | 4450 |
|
2024
Q1 | $37K | Hold |
11,124
| – | – | ﹤0.01% | 4377 |
|
2023
Q4 | $17.6K | Hold |
11,124
| – | – | ﹤0.01% | 4534 |
|
2023
Q3 | $16.6K | Hold |
11,124
| – | – | ﹤0.01% | 4657 |
|
2023
Q2 | $22.6K | Hold |
11,124
| – | – | ﹤0.01% | 4646 |
|
2023
Q1 | $18.5K | Hold |
11,124
| – | – | ﹤0.01% | 4712 |
|
2022
Q4 | $38K | Hold |
11,124
| – | – | ﹤0.01% | 4665 |
|
2022
Q3 | $50K | Hold |
11,124
| – | – | ﹤0.01% | 4764 |
|
2022
Q2 | $31K | Hold |
11,124
| – | – | ﹤0.01% | 4863 |
|
2022
Q1 | $48K | Buy |
11,124
+1,038
| +10% | +$4.48K | ﹤0.01% | 4813 |
|
2021
Q4 | $55K | Hold |
10,086
| – | – | ﹤0.01% | 4842 |
|
2021
Q3 | $59K | Sell |
10,086
-2,911
| -22% | -$17K | ﹤0.01% | 4761 |
|
2021
Q2 | $141K | Buy |
+12,997
| New | +$141K | ﹤0.01% | 4465 |
|